Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | GABRP | O00591 | 1/20 | 0.38 |
| ▸ | GABRD | O14764 | 1/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.38 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.38 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.38 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.38 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.38 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.38 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.38 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.38 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.38 |
| ▸ | GABRE | P78334 | 1/20 | 0.38 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.38 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.38 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.38 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6053024 | 0.67 | — | — | |
| SCHEMBL8007269 | 0.67 | TSHR (0.36) | TSHRGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL1355407 | 0.66 | TSHR (0.42) | TSHRGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL28787332 | 0.64 | OAT (0.36) | TSHRGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL27696111 | 0.64 | — | — | |
| SCHEMBL6224633 | 0.64 | — | — | |
| SCHEMBL10523922 | 0.64 | — | — | |
| SCHEMBL14293551 | 0.64 | — | — | |
| SCHEMBL3649681 | 0.62 | TSHR (0.36) | TSHRGABRPGABRDGABRA1GABRB1 | |
| SCHEMBL9468314 | 0.61 | CES2 (0.47) | TSHRGABRPGABRDGABRA1GABRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011119637-A9 | PREDICTING HUMAN DEVELOPMENTAL TOXICITY OF PHARMACEUTICALS USING HUMAN STEM-LIKE CELLS AND METABOLOMICS | STEMINA BIOMARKER DISCOVERY, INC. (US) | 2015-12-10 | — | — | WO | claimed |
| EP-2550365-A1 | PREDICTING HUMAN DEVELOPMENTAL TOXICITY OF PHARMACEUTICALS USING HUMAN STEM-LIKE CELLS AND METABOLOMICS | Stemina Biomarker Discovery, Inc. (US) | 2013-01-30 | — | — | EP | claimed |
| WO-2011119637-A1 | PREDICTING HUMAN DEVELOPMENTAL TOXICITY OF PHARMACEUTICALS USING HUMAN STEM-LIKE CELLS AND METABOLOMICS | STEMINA BIOMARKER DISCOVERY, INC. (US) | 2011-09-29 | — | — | WO | claimed |
| WO-2025072741-A1 | PRESERVATIVES FOR MOLECULAR SAMPLE ANALYSIS WITH SAMPLE COLLECTION DEVICES | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-04-03 | — | — | WO | disclosed |
| CN-104822843-B | Predicting human developmental toxicity of drugs using human stem-like cells and metabolomic ratios | 施特米纳生物标记研发公司 | 2020-01-21 | — | — | CN | disclosed |
| US-20190128872-A1 | PREDICTING HUMAN DEVELOPMENTAL TOXICITY OF PHARMACEUTICALS USING HUMAN STEM-LIKE CELLS AND METABOLOMIC RATIOS | STEMINA BIOMARKER DISCOVERY, INC. | 2019-05-02 | — | — | US | disclosed |
| EP-2914748-B1 | PREDICTING HUMAN DEVELOPMENTAL TOXICITY OF PHARMACEUTICALS USING HUMAN STEM-LIKE CELLS AND METABOLOMIC RATIOS | STEMINA BIOMARKER DISCOVERY INC (US) | 2019-03-13 | — | — | EP | disclosed |
| US-10209240-B2 | Predicting human developmental toxicity of pharmaceuticals using human stem-like cells and metabolomic ratios | STEMINA BIOMARKER DISCOVERY, INC. (US) | 2019-02-19 | — | — | US | disclosed |
| US-20180128814-A1 | PREDICTING HUMAN DEVELOPMENTAL TOXICITY OF PHARMACEUTICALS USING HUMAN STEM-LIKE CELLS AND METABOLOMIC RATIOS | STEMINA BIOMARKER DISCOVERY, INC. | 2018-05-10 | — | — | US | disclosed |
| US-9932309-B2 | 2-oxo-3,4-dihydropyridine-5-carboxylates and their use | UNIVERSITE DE LILLE 2 DROIT ET SANTE (FR) | 2018-04-03 | — | — | US | disclosed |
| EP-2013619-B1 | METHODS FOR USING HUMAN EMBRYONIC STEM CELLS TO EVALUATE TOXICITY OF PHARMACEUTICAL COMPOUNDS & OTHER CHEMICALS | WISCONSIN ALUMNI RES FOUND (US) | 2017-10-11 | — | — | EP | disclosed |
| US-20150301025-A1 | PREDICTING HUMAN DEVELOPMENTAL TOXICITY OF PHARMACEUTICALS USING HUMAN STEM-LIKE CELLS AND METABOLOMIC RATIOS | STEMINA BIOMARKER DISCOVERY, INC. (US) | 2015-10-22 | — | — | US | disclosed |
| EP-2914748-A1 | PREDICTING HUMAN DEVELOPMENTAL TOXICITY OF PHARMACEUTICALS USING HUMAN STEM-LIKE CELLS AND METABOLOMIC RATIOS | Stemina Biomarker Discovery, Inc. (US) | 2015-09-09 | — | — | EP | disclosed |
| WO-2014071137-A1 | PREDICTING HUMAN DEVELOPMENTAL TOXICITY OF PHARMACEUTICALS USING HUMAN STEM-LIKE CELLS AND METABOLOMIC RATIOS | STEMINA BIOMARKER DISCOVERY, INC. (US) | 2014-05-08 | — | — | WO | disclosed |